SEC Form 4 · accession 0001144204-17-044642
BIOHITECH GLOBAL, INC. · BHTG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Aug 17, 2017
Accepted (ET)
Aug 22, 2017 · 5:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590383
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Promissory NoteF3,F1,F2 | $2.75 | Aug 17, 2017 | X | 1 | A | Aug 17, 2017 | Jul 6, 2019 | Common Stock | 9,091 | 1 | I |
| WarrantsF4,F5 | $3.30 | Aug 17, 2017 | X | 9,091 | A | Aug 17, 2017 | Aug 17, 2022 | Common Stock | 9,091 | 9,091 | I |
Explanation of responses
- F1Represents the highest possible conversion price of the note.
- F2Represents the number of shares of common stock, par value $$0.0001 per share ("Common Stock") into which the note is convertible based on the conversion price of $2.75 per share. The note is convertible into an indeterminable number of shares.
- F3Does not include 799,877 shares held by Penn Venture Partners, L.P. ("Penn Venture") over which Mr. Graham holds voting and dispositive power. The address of Penn Venture is 132 State Street, Harrisburg, PA 12101.
- F4Based on 120% of the conversion price of $2.75 per share. The warrants are exercisable into an indeterminable number of shares.
- F5Represents the number of shares of Common Stock into which the warrants are exercisable based on the exercise price of $3.30 per share.